Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review
The Journal of Clinical Endocrinology & Metabolism · 19.04.2024 · 109 (5) · 1189-1197
DOI: 10.1210/clinem/dgad704 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.12.2023. Verfasst von Aleena Shujaat Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Melbourne, Melbourne 3084, Australia. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Genetic Predisposition to Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Australian Research Programme.
Abstract (Originalsprache)
Context
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. Measures to prevent and treat DKD require better identification of patients most at risk. In this systematic review, we summarize the existing evidence of genetic risk scores (GRSs) and their utility for predicting DKD in people with type 1 or type 2 diabetes. Evidence Acquisition We searched MEDLINE, Embase, Web of Science, and Cochrane Reviews in June 2022 to identify all existing and relevant literature. Main data items sought were study design, sample size, population, single nucleotide polymorphisms of interest, DKD-related outcomes, and relevant summary measures of result. The Critical Appraisal Skills Programme checklist was used to evaluate the methodological quality of studies. Evidence Synthesis We identified 400 citations of which 15 are included in this review. Overall, 7 studies had positive results, 5 had mixed results, and 3 had negative results. Most studies with the strongest methodological quality (n = 9) reported statistically significant and favourable findings of a GRS’s association with at least 1 measure of DKD.
Conclusion
This systematic review presents evidence of the utility of GRSs to identify people with diabetes that are at high risk of developing DKD. In practice, a robust GRS could be used at the first clinical encounter with a person living with diabetes in order to stratify their risk of complications. Further prospective research is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, The University of Melbourne, Melbourne 3084, Australia.
- Australian Centre for Accelerating Diabetes Innovations, The University of Melbourne, Melbourne 3000, Australia.
- Diabetes Research Foundation, The University of Western Australia, Perth 6009, Australia.
- Department of Endocrinology, Austin Health, Melbourne 3084, Australia.
ORCID-Profile: Aleena Shujaat Ali, Elif Ilhan Ekinci
Förderung
- Diabetes Australian Research Programme
Zitieren
APA
Ali, A. S., Pham, C., Morahan, G., & Ekinci, E. I. (2024). Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism, 109(5), 1189-1197. https://doi.org/10.1210/clinem/dgad704
Vancouver
Ali AS, Pham C, Morahan G, Ekinci EI. Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism. 2024;109(5):1189-1197. doi:10.1210/clinem/dgad704
BibTeX
@article{Ali2024,
author = {Ali, Aleena Shujaat and Pham, Cecilia and Morahan, Grant and Ekinci, Elif Ilhan},
title = {Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {5},
pages = {1189--1197},
doi = {10.1210/clinem/dgad704}
}
EUVIMED